1.1701

0.84% -0.0099

After Hours: 1.14 -0.0301 -2.57%

Clearmind Medicine Inc (CMND)

Overview News Price History Why CMND Down? Discussions Forecast Stock Split

Clearmind Medicine Inc stock is currently priced at $1.1701, with a 24-hour trading volume of 45,655. It has seen a -0.84% decreased in the last 24 hours and a +8.34% rose in the past month. The chart indicates a potential bearish trend, as the stock is below the $1.18 pivot point. If it approaches the $1.16 support level, significant changes may occur.

Previous Close:

$1.18

Open:

$1.17

24h Volume:

45,655

Market Cap:

$3.82M

Revenue:

Net Income/Loss:

$-6.78M

P/E Ratio:

-0.3275

EPS:

-3.5729

Net Cash Flow:

$-4.67M

1W Performance:

-2.49%

1M Performance:

+8.34%

6M Performance:

+741.80%

1Y Performance:

+108.65%

1D Range:

$1.15

$1.21

52W Range:

$0.10

$6.80

Clearmind Medicine Inc Stock (CMND) Company Profile

Name

Clearmind Medicine Inc

Sector

Healthcare (1190)

Industry

Biotechnology (681)

Phone

604 260 1566

Address

1220 West 6th Avenue, Suite 101, Vancouver

Employee

Twitter

Next Earnings Date

Latest SEC Filings

CMND's Discussions on Twitter

Clearmind Medicine Inc Stock (CMND) Latest News

Clearmind Applies to Cease Being a Reporting Issuer in Canada

GlobeNewswire Inc.

Clearmind Medicine Announces Exclusive Licensing Agreement for Generation 3.0 Psychedelic Compounds for the Treatment of Mental Disorders

GlobeNewswire Inc.

Clearmind Medicine Files U.S. Patent Application for Psychedelic-Based Treatment for Eating Disorders

GlobeNewswire Inc.

Clearmind Medicine CEO Issues Letter to Shareholders

GlobeNewswire Inc.

Clearmind Medicine Announces International Patent Application for Preventing and Treating Depression

GlobeNewswire Inc.

Why Taysha Gene Therapies Shares Are Trading Higher By Around 27%; Here Are 20 Stocks Moving Premarket

Benzinga

Clearmind Medicine Inc Stock (CMND) Financials Data

Clearmind Medicine Inc (CMND) Net Income 2024

CMND net income (TTM) was -$6.78 million for the quarter ending October 31, 2023, a -16.68% decrease year-over-year.

Clearmind Medicine Inc (CMND) Cash Flow 2024

CMND recorded a free cash flow (TTM) of -$4.67 million for the quarter ending October 31, 2023, a -61.42% decrease year-over-year.

Clearmind Medicine Inc (CMND) Earnings per Share 2024

CMND earnings per share (TTM) was -$42.70 for the quarter ending October 31, 2023, a +68.02% growth year-over-year.

Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.